Last $31.55 USD
Change Today 0.00 / 0.00%
Volume 0.0
STDAF On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Axel Müller

Former Chief Production & Development Officer and Member of The Executive Board, Stada-Arzneimittel AG
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

57€1,147,200
As of Fiscal Year 2013

Background*

Dr. Axel Müller served as the Chief Production & Development Officer of Stada-Arzneimittel AG from September 16, 2010 to August 7, 2013 and served as its Executive Board Member since 2010. Dr. Müller served as an Exclusive Consultant for numerous international Group projects and periodic assumption of operating management tasks in the STADA Group (since 2005 as Vice President, since 2008 as Senior Vice President), among other things, country responsibility for Switzerland ...

Read Full Background

Corporate Headquarters*

Stadastrasse 2-18
Bad Vilbel, -- 61118

Germany

Phone: 49 6101 6030
Fax: 49 6101 603 259

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary€750,000
Bonus€375,000
Total Annual Compensation€1,125,000

Stock Options*

All Other Compensation€22,200

Total Compensation*

Total Annual Cash Compensation€1,147,200
Total Short Term Compensation€1,125,000
Other Long Term Compensation€22,200
Total Calculated Compensation€1,147,200
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STDAF:US $31.55 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian R. Garland Chief Executive Officer, Director and Member of Nominations & Corporate Governance Committee
Vernalis plc
610.0K GBP
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
John Dawson Chief Executive Officer and Director
Oxford BioMedica PLC
429.0K GBP
Erik Bogsch Managing Director, Chief Executive Officer, Member of Executive Board and Director
Chemical Works of Gedeon Richter Plc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STADA ARZNEIMITTEL AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.